《A phototheranostic nanoparticle for cancer therapy fabricated by BODIPY and graphene to realize photo-chemo synergistic therapy and fluorescence/photothermal imaging》 was written by Su, Yu; Wang, Ning; Liu, Bingjie; Du, Yingying; Li, Ruonan; Meng, Yang; Feng, Yaqing; Shan, Zhongqiang; Meng, Shuxian. HPLC of Formula: 5471-63-6 And the article was included in Dyes and Pigments in 2020. The article conveys some information:
Phototheranostic agents are capable of both therapeutic and diagnostic potential, making them a promising strategy for cancer therapy. BODIPY is an outstanding photosensitizer for Photodynamic Therapy (PDT). Here we engineered a BODIPY-based phototheranostic nanoparticle with photo-chemo synergistic property and the nanoparticle MMC-Graphene@BODIPY-mPEG (MGBP) possesses excellent ROS production ability, high photothermal conversion efficiency (48%), and excellent therapy efficiency (HeLa cell viability was down to 17% after treatment) in vitro. Furthermore, because of its high fluorescence and anti-photobleaching ability of BODIPY and photothermal conversion ability of Graphene, MGBP showed superior fluorescence and photothermal imaging ability in the agar model. In summary, MGBP possessed the excellent potential for tumor tissue imaging-guided photo-chemo synergistic therapy.1,3-Diphenylisobenzofuran(cas: 5471-63-6HPLC of Formula: 5471-63-6) was used in this study.
1,3-Diphenylisobenzofuran(cas: 5471-63-6) can be used as a fluorescent probe for detection of superoxide anion radical (O2−) inside the membrane lipid layer by DPBF fluorescence quenching method. 1,3-Diphenylisobenzofuran(DPBF) can be used as quencher during the photoinactivation of TA-3 mouse mammary carcinoma cells containing hematoporphyrin.HPLC of Formula: 5471-63-6
Referemce:
Benzofuran – Wikipedia,
Benzofuran | C8H6O – PubChem